It’s a done deal before September 1, 2022.
Repligen on the block to be sold
Unable to move the growth needle puts Repligen in play with being sold, most likely before the end of 2022. In August the company started promoting folks to VP’s, stock jumps to 250+ range while M&A stalls and expansions go to bust in failure. Rancho... — read more